The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Ulrika Ericson

Ulrika Ericson

Associate professor

Ulrika Ericson

Dietary Flavonoid Intake and Esophageal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Cohort


  • Esther Vermeulen
  • Raul Zamora-Ros
  • Eric J. Duell
  • Leila Lujan-Barroso
  • Heiner Boeing
  • Krasimira Aleksandrova
  • H. Bas Bueno-de-Mesquita
  • Augustin Scalbert
  • Isabelle Romieu
  • Veronika Fedirko
  • Marina Touillaud
  • Guy Fagherazzi
  • Florence Perquier
  • Esther Molina-Montes
  • Maria-Dolores Chirlaque
  • Marcial Vicente Argueelles
  • Pilar Amiano
  • Aurelio Barricarte
  • Valeria Pala
  • Amalia Mattiello
  • Calogero Saieva
  • Rosario Tumino
  • Fulvio Ricceri
  • Antonia Trichopoulou
  • Effie Vasilopoulou
  • Gianna Ziara
  • Francesca L. Crowe
  • Kay-Thee Khaw
  • Nicholas J. Wareham
  • Effie Vasilopoulou
  • Gianna Ziara
  • Francesca L. Crowe
  • Kay-Thee Khaw
  • Nicholas J. Wareham
  • Annekatrin Lukanova
  • Verena A. Grote
  • Anne Tjonneland
  • Jytte Halkjaer
  • Lea Bredsdorff
  • Kim Overvad
  • Peter D. Siersema
  • Petra H. M. Peeters
  • Anne M. May
  • Elisabete Weiderpass
  • Guri Skeie
  • Anette Hjartaker
  • Rikard Landberg
  • Ingegerd Johansson
  • Emily Sonestedt
  • Ulrika Ericson
  • Elio Riboli
  • Carlos A. Gonzalez

Summary, in English

We prospectively investigated dietary flavonoid intake and esophageal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The study included 477,312 adult subjects from 10 European countries. At baseline, country-specific validated dietary questionnaires were used. During a mean follow-up of 11 years (1992-2010), there were 341 incident esophageal cancer cases, of which 142 were esophageal adenocarcinoma (EAC), 176 were esophageal squamous cell carcinoma (ESCC), and 23 were other types of esophageal cancer. In crude models, a doubling in total dietary flavonoid intake was inversely associated with esophageal cancer risk (hazard ratio (HR) (log(2))=0.87, 95% confidence interval (CI): 0.78, 0.98) but not in multi-variable models (HR (log(2))=0.97, 95% CI: 0.86, 1.10). After covariate adjustment, no statistically significant association was found between any flavonoid subclass and esophageal cancer, EAC, or ESCC. However, among current smokers, flavonols were statistically significantly associated with a reduced esophageal cancer risk (HR (log(2)) = 0.72, 95% CI: 0.56, 0.94), whereas total flavonoids, flavanols, and flavan-3-ol monomers tended to be inversely associated with esophageal cancer risk. No associations were found in either never or former smokers. These findings suggest that dietary flavonoid intake was not associated with overall esophageal cancer, EAC, or ESCC risk, although total flavonoids and some flavonoid subclasses, particularly flavonols, may reduce the esophageal cancer risk among current smokers.


  • Diabetes - Cardiovascular Disease
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year







American Journal of Epidemiology





Document type

Journal article


Oxford University Press


  • Public Health, Global Health, Social Medicine and Epidemiology


  • esophageal cancer
  • European Prospective Investigation into Cancer and
  • Nutrition
  • flavonoids
  • intake



Research group

  • Diabetes - Cardiovascular Disease


  • ISSN: 0002-9262